Company / Net Income
Stoke Therapeutics, Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$6.9M
FY2025
5-year range
-$104.7M / -$6.9M
FY2021-FY2025
Trend
+93.4%
vs FY2024
Sector context
#64 of 216
Health Care
What the data says
At -$7M, Stoke Therapeutics, Inc.'s net income ranks #64 of 216 in the Health Care sector. Net Income returned to growth in FY2025 after 2 years of decline, reaching -$7M.
Based on SEC 10-K filings.
-$7M in FY2025.
Improved from -$101M to -$7M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#64 of 216 in Health CareTop 30% of 216This company -$6.9M Sector average $454.3M
▼
-101.5% below sector average
Key checks
Key Insights
- In FY2025, net income increased 93.4% year-over-year.
- Ranks #64 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.9M | +93.4% |
| FY2024 | -$104.7M | -3.6% |
| FY2023 | -$101.1M | -17.8% |
| FY2022 | -$85.8M | +0.0% |
| FY2021 | -$85.8M | -64.2% |
| FY2020 | -$52.2M | -61.6% |
| FY2019 | -$32.3M | -158.2% |
| FY2018 | -$12.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026